RIFAXIMIN
Semi-synthetic antibiotic derived from Rifamycin
Specification – pharmacopeia: EP, BP, In House
Therapeutic category: antibiotic (travelers’ diarrhea)
Treatment: for traveler's diarrhea, produced by non-invasive strains of Escherichia coli.
Pharmacology: prevents the synthesis of DNA from the bacterium by binding to the RNA polymerase; thus it is not absorbed in the digestive tract, is used as an intestinal antibiotic.
Application: human & veterinary
CAS number: 80621-81-4
Chemical formula: C43H51N3O11
sales@interquim.com.mx